Shenzhen Noposion Crop Science Co., Ltd.

XSEC:002215 Stock Report

Market Cap: CN¥9.3b

Shenzhen Noposion Crop Science Valuation

Is 002215 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 002215 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 002215 (CN¥9.4) is trading above our estimate of fair value (CN¥4.79)

Significantly Below Fair Value: 002215 is trading above our estimate of fair value.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for 002215?

Key metric: As 002215 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 002215. This is calculated by dividing 002215's market cap by their current earnings.
What is 002215's PE Ratio?
PE Ratio21x
EarningsCN¥443.11m
Market CapCN¥9.31b

Price to Earnings Ratio vs Peers

How does 002215's PE Ratio compare to its peers?

The above table shows the PE ratio for 002215 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average18.8x
002004 Huapont Life SciencesLtd
37.3xn/aCN¥9.3b
002539 Chengdu Wintrue Holding
11.6x21.8%CN¥9.8b
603599 Anhui Guangxin Agrochemical
15.1x30.1%CN¥10.4b
002588 Stanley Agriculture GroupLtd
11.2x12.8%CN¥8.8b
002215 Shenzhen Noposion Crop Science
21x32.4%CN¥9.3b

Price-To-Earnings vs Peers: 002215 is expensive based on its Price-To-Earnings Ratio (21x) compared to the peer average (18.8x).


Price to Earnings Ratio vs Industry

How does 002215's PE Ratio compare vs other companies in the CN Chemicals Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
No more companies available in this PE range
002215 21.0xIndustry Avg. 35.6xNo. of Companies42PE020406080100+
0 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: 002215 is good value based on its Price-To-Earnings Ratio (21x) compared to the CN Chemicals industry average (35.1x).


Price to Earnings Ratio vs Fair Ratio

What is 002215's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

002215 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio21x
Fair PE Ratio25.7x

Price-To-Earnings vs Fair Ratio: 002215 is good value based on its Price-To-Earnings Ratio (21x) compared to the estimated Fair Price-To-Earnings Ratio (25.7x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 002215 forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentCN¥9.40
CN¥12.66
+34.7%
2.7%CN¥13.00CN¥12.32n/a2
Nov ’25CN¥9.06
CN¥12.66
+39.7%
2.7%CN¥13.00CN¥12.32n/a2
Oct ’25CN¥9.01
CN¥12.66
+40.5%
2.7%CN¥13.00CN¥12.32n/a2
Sep ’25CN¥7.24
CN¥12.66
+74.9%
2.7%CN¥13.00CN¥12.32n/a2
Aug ’25CN¥6.81
CN¥12.66
+85.9%
2.7%CN¥13.00CN¥12.32n/a2
Jul ’25CN¥7.62
CN¥12.66
+66.1%
2.7%CN¥13.00CN¥12.32n/a2
Jun ’25CN¥8.17
CN¥12.66
+55.0%
2.7%CN¥13.00CN¥12.32n/a2
May ’25CN¥8.91
CN¥12.77
+43.3%
1.8%CN¥13.00CN¥12.54n/a2
Apr ’25CN¥8.58
CN¥12.77
+48.8%
1.8%CN¥13.00CN¥12.54n/a2
Mar ’25CN¥8.44
CN¥12.27
+45.4%
2.2%CN¥12.54CN¥12.00n/a2
Feb ’25CN¥6.98
CN¥12.27
+75.8%
2.2%CN¥12.54CN¥12.00n/a2
Jan ’25CN¥8.26
CN¥12.27
+48.5%
2.2%CN¥12.54CN¥12.00n/a2
Dec ’24CN¥9.07
CN¥11.17
+23.2%
7.4%CN¥12.00CN¥10.34n/a2

Analyst Forecast: Target price is more than 20% higher than the current share price, but there are not enough analysts covering the stock to determine statistical confidence in agreement.


Discover undervalued companies